That's a good point, more relevant to the US than RoW, but still a good point. The main issue is that you run into a chicken/egg problem: to lower the cost the

That's a good point, more relevant to the US than RoW, but still a good point. The main issue is that you run into a chicken/egg problem: to lower the cost the government needs to develop alternative drugs, but won't have the money to do so unless you lower the cost.